Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

COVID-19 monoclonal antibodies are a bridge to vaccination

Priya Nori, MD and Liise-anne Pirofski, MD
Meds
December 18, 2021
16 Shares
Share
Tweet
Share

Attention-grabbing headlines suggest that our crucial COVID-19 pandemic tools—monoclonal antibodies and vaccines—are incompatible. Beyond the controversy rests an evidence-based reality: monoclonal antibodies and vaccines are complementary aspects of patient care. Both are powerful interventions that can prevent hospitalizations and deaths from this virus. After weeks of declining cases and hospitalizations, the United States is experiencing another surge of new infections likely due to multiple factors, including relaxed mask use in indoor spaces, possible waning immunity from one- or two-dose vaccine schedules, holiday gatherings, colder weather, etc. Therefore, it is time to put aside the ideological divide and embrace monoclonal antibodies and vaccines as complementary tools to confront and restrain COVID-19.

Our hospital in the Bronx, NY, was devastated by COVID-19 in the Spring of 2020, but subsequent waves have been smaller and less deadly due in part to the success of offering both interventions in parallel, monoclonal antibodies for the treatment of COVID-infected patients, and vaccinations for prevention.

In the 12 months since monoclonal antibody therapies received federal government emergency use authorization, health care systems nationwide have worked tirelessly to create an infrastructure to treat at-risk communities, some of whom also suffer a disproportionate toll from COVID-19 due to structural racism and poor social determinants of health. Along the way, monoclonal antibodies served as a bridge that enabled us to counsel patients about their health risks and the importance of vaccines. It is a successful approach that can be replicated anywhere.

A recent patient was a young, unvaccinated single mother suffering from high fevers, body aches, shortness of breath, and chest tightness from a COVID-induced asthma attack. She had not yet been vaccinated and stated that neither she nor her children would receive the vaccine. She told us she did not trust it and was afraid of its side effects. However, she was unaware of the potential ravages of COVID-19, including the possibility of dying and orphaning young children. Similarly, she was hesitant about monoclonal antibody therapy, but ultimately agreed to the treatment since it could alleviate her suffering. COVID-19 left her unable to care for her children for many days and sickened at least three other members of her household. She acknowledges that her family’s circumstance could have been different had she been vaccinated and is now amenable to getting her family vaccinated as soon as possible.

Successes like this are possible when clinicians and patients understand the facts about COVID-19 vaccines and monoclonal antibodies and patients are presented with accurate information. Both agents underwent an accelerated but scientifically rigorous evaluation from initial discovery to large clinical trials, to robust data review by FDA scientists. Both act via anti-spike protein antibodies that either passively (monoclonal antibodies) or actively (vaccines) prevent progression of SARS-CoV- 2 infection. Both can mitigate illness and decrease viral shedding, which benefits the individual and possibly, close contacts. Monoclonal antibodies, like vaccines, also play a role in prevention within specific populations, like severely immunocompromised individuals who have been exposed to the virus.

One important difference between monoclonals and vaccines is the duration and breadth of protection. Vaccines prime a variety of immune cells to quickly respond to future threats, while monoclonal antibodies provide immediate protection that may be therapeutic in vaccine naïve persons and when vaccine-mediated antibodies wane and breakthrough infections occur. Also, unlike COVID-19 vaccines, which are widely available and accessible, persons eligible for monoclonal antibodies must meet certain qualifications and receive treatment, often in a medical setting, shortly after diagnosis. Finally, unlike vaccines, monoclonal antibodies will not bring us closer to ending the pandemic, but can reduce pressure on overburdened emergency rooms, hospitals, and health care workers.

Facing a limited supply of monoclonal antibodies and increasing numbers of vaccine breakthrough infections (due to high rates of SARS-CoV-2 infections in the community and waning antibody levels from original vaccinations), monoclonal antibody programs may be tasked with deciding between treatment of unvaccinated persons and vulnerable, vaccinated individuals. This would heighten moral injury experienced by clinicians and exacerbate “compassion fatigue” toward the unvaccinated. Therefore, it is incumbent on health care systems to continue to offer these life-saving treatments while promoting vaccination and other proven public health interventions.

The approach of our program—monoclonals today, vaccines tomorrow—stresses a dual path that acknowledges the complementary nature of these tools and builds lasting relationships with our patients. Monoclonal antibody treatment encounters provide an opportunity to debunk social media and cultural misinformation, and become a trusted resource for vaccine facts, and ultimately vaccination, once patients are ready. This strategy is increasingly important as new SARS-CoV-2 variants take hold in our communities, emphasizing the need to urgently vaccinate as many eligible individuals as possible

Our patient decided that vaccination is part of her responsibility to her children—an example of what is possible with shared medical decision-making built on trust and respect. Each referral for antibody treatment presents a valuable opportunity to educate, develop relationships with patients and their families, build public confidence, and ensure the health of our communities through future vaccination.

Priya Nori and Liise-anne Pirofski are infectious disease physicians. This article originally appeared in The Doctor’s Tablet.

Image credit: Shutterstock.com

Prev

Diabetes impacts the whole body, but the foot can't be forgotten

December 18, 2021 Kevin 0
…
Next

Educating for the oath: a medical student's lived experience with the hidden curriculum

December 18, 2021 Kevin 0
…

Tagged as: COVID

Post navigation

< Previous Post
Diabetes impacts the whole body, but the foot can't be forgotten
Next Post >
Educating for the oath: a medical student's lived experience with the hidden curriculum

Related Posts

  • High COVID-19 vaccination rates do not equate to equity in communities of color

    Ira Memaj, MPH, Joshua Anthony, MD, MBA, and Robert Fullilove, EdD
  • How to get patients vaccinated against COVID-19 [PODCAST]

    The Podcast by KevinMD
  • COVID-19 divides and conquers

    Michele Luckenbaugh
  • State sanctioned executions in the age of COVID-19

    Kasey Johnson, DO
  • A patient’s COVID-19 reflections

    Michele Luckenbaugh
  • Starting medical school in the midst of COVID-19

    Horacio Romero Castillo

More in Meds

  • Levamisole is good for your dog, but bad for your cocaine

    Robert Killeen, MD
  • 13.1 million missing Americans since 1980. Where’s the outrage?

    Steve Burgess, MD
  • Ketamine for mental health conditions: What every primary care physician needs to know

    Carlene MacMillan, MD & L. Alison McInnes, MD
  • Learn to be a Narcan hero: a comic tutorial

    Emily Watters, MD
  • The preference for insurance coverage of opioids over non-pharmaceutical options explained

    Amy Baxter, MD
  • A comic reveals the terrifying truth about fentanyl

    Emily Watters, MD
  • Most Popular

  • Past Week

    • Challenging the diagnosis: dehydration or bias?

      Sydney Lou Bonnick, MD | Physician
    • A teenager’s perspective: the pressing need for mental health days in schools

      Ruhi Saldanha | Conditions
    • Understanding reproductive rights: complex considerations

      Anonymous | Physician
    • COVID-19 unleashed an ongoing crisis of delirium in hospitals

      Christina Reppas-Rindlisbacher, MD, Nathan Stall, MD, and Paula Rochon, MD | Conditions
    • Air quality alert: Reducing our carbon footprint in health care

      Shreya Aggarwal, MD | Conditions
    • America’s young men are facing a mental health crisis. Can we help them before it’s too late?

      Henna Hundal and Karan Patel | Conditions
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • Unveiling excessive medical billing and greed

      Amol Saxena, DPM, MPH | Policy
    • The erosion of patient care

      Laura de la Torre, MD | Physician
    • I’m a doctor, and I almost died during childbirth

      Bayo Curry-Winchell, MD | Physician
  • Recent Posts

    • Pioneering space race research: G-forces and human physiology

      Earl Howard Wood, MD, PhD | Conditions
    • How to pick the right mutual funds to reduce your taxes

      Amarish Dave, DO | Finance
    • What is the physician’s role in the food is medicine movement?

      Deb Kennedy, PhD | Conditions
    • America’s young men are facing a mental health crisis. Can we help them before it’s too late?

      Henna Hundal and Karan Patel | Conditions
    • When physicians are disrespected [PODCAST]

      The Podcast by KevinMD | Podcast
    • Addressing dual diagnosis needs in addiction treatment

      Susan Hertz Berrick, EdD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Use of Recent Diagnostic CT Scans for Palliative RT Planning Reduced Treatment Time
  • Pediatric EDs Able to Sway Some Families, Clinicians on Penicillin Challenge
  • Drugmaker Plans to Pull Lung Cancer Drug From the Market
  • Spell Check-Up: Is Your Spelling Up to Snuff?
  • Coast to Coast, Kaiser Permanente Workers Start 3-Day Strike

Meeting Coverage

  • Use of Recent Diagnostic CT Scans for Palliative RT Planning Reduced Treatment Time
  • Hypofractionated RT for Breast Cancer Post-Mastectomy as Effective as Standard RT
  • SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancer
  • Mixed Bag for Early Metformin in Gestational Diabetes
  • Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D
  • Most Popular

  • Past Week

    • Challenging the diagnosis: dehydration or bias?

      Sydney Lou Bonnick, MD | Physician
    • A teenager’s perspective: the pressing need for mental health days in schools

      Ruhi Saldanha | Conditions
    • Understanding reproductive rights: complex considerations

      Anonymous | Physician
    • COVID-19 unleashed an ongoing crisis of delirium in hospitals

      Christina Reppas-Rindlisbacher, MD, Nathan Stall, MD, and Paula Rochon, MD | Conditions
    • Air quality alert: Reducing our carbon footprint in health care

      Shreya Aggarwal, MD | Conditions
    • America’s young men are facing a mental health crisis. Can we help them before it’s too late?

      Henna Hundal and Karan Patel | Conditions
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • Unveiling excessive medical billing and greed

      Amol Saxena, DPM, MPH | Policy
    • The erosion of patient care

      Laura de la Torre, MD | Physician
    • I’m a doctor, and I almost died during childbirth

      Bayo Curry-Winchell, MD | Physician
  • Recent Posts

    • Pioneering space race research: G-forces and human physiology

      Earl Howard Wood, MD, PhD | Conditions
    • How to pick the right mutual funds to reduce your taxes

      Amarish Dave, DO | Finance
    • What is the physician’s role in the food is medicine movement?

      Deb Kennedy, PhD | Conditions
    • America’s young men are facing a mental health crisis. Can we help them before it’s too late?

      Henna Hundal and Karan Patel | Conditions
    • When physicians are disrespected [PODCAST]

      The Podcast by KevinMD | Podcast
    • Addressing dual diagnosis needs in addiction treatment

      Susan Hertz Berrick, EdD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

COVID-19 monoclonal antibodies are a bridge to vaccination
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...